Robbins LLP is Investigating Allegations that The Chemours Company (CC) Materially Overstated Market Demand for Its Products

Robbins LLP informs investors that a class action was filed on behalf of persons or entities who purchased or otherwise acquired The Chemours Company (NYSE: CC) securities between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). Chemours offers a range of industrial and specialty chemical products for markets including, refrigeration and air conditioning.

Why Was Chemours Sued?

The complaint alleges that, during the Class Period, defendants failed to disclose that:

(i) defendants had materially overstated aftermarket demand for their Opteon products;

(ii) demand for such products was decreasing because of defendants’ overselling Opteon products in the preceding fiscal year;

(iii) as a result of these undisclosed issues, defendants’ financial guidance for the 2026 fiscal year was unreliable; and

(iv) as a result, defendants’ public statements were materially false and misleading at all relevant times.

Why Did Chemours Stock Drop?

Plaintiff alleges that on August 4, 2026, after market hours, Chemours announced second quarter 2026 financial results. Among other things, the Company reduced its adjusted EBITDA full-year guidance to $775 million to $825 million (from $800 million to $900 million previously). Further, on the accompanying earnings call, management admitted that “[a]s a result of the initial channel fill, aftermarket customers built additional inventory, creating an oversupplied channel heading into 2026.” Management further disclosed “from the Q2 and Q3 perspective, there’s probably about $65 million of aftermarket sales that realistically, you think about like-for-like probably should have been allocated to more of this year.” On this news, Chemours’s stock price fell $3.34 per share, or 18.63%, to close at $14.59 per share on August 5, 2026.

Who May Be Eligible to Participate in The Chemours Company Class Action?

The lawsuit seeks to represent investors who purchased or otherwise acquired The Chemours Company securities between February 20, 2026 and August 4, 2026. Investors who suffered losses during that period may have legal rights under the federal securities laws. Submit a form for information.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.